Oruka Therapeutics, Inc.
ORKA • XNAS • Stock Fundamentals
Oruka Therapeutics, Inc. is a in vitro & in vivo diagnostic substances company trading on XNAS, led by CEO Lawrence Otto Klein, with a market cap of $4.1B.
Market Cap$4.1B
CEOLawrence Otto Klein
CountryUnited States of America
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Most Recent EarningsMay 13, 2026 · 1 month 1 day agoQ1 2026
View reportNext EarningsAug 10, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Oruka Therapeutics, Inc. FAQ
Common questions about Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. (ORKA) has a market capitalization of $4.1B and trades on XNAS.